Synapse - David Scheinberg

Results (13)

Alpha-particle emitting atomic generator (actinium-225)-labeled trastuzumab (Herceptin) targeting of breast cancer spheroids: Efficacy versus HER2/neu expression

Journal Article

Ballangrud, A. M.; Yang, W. H.; Palm, S.; Enmon, R.; Borchardt, P. E.; Pellegrini, V.; McDevitt, M. R.; Scheinberg, D. A.; Sgouros, G.
Clinical Cancer Research (2004)

Fulltext@MSK | Save

Alpha-particle emitter (225Ac)-labeled Herceptin antibody targeting of breast cancer: Efficacy vs HER-2/neu expression

Meeting Abstract

Ballangrud, A. M.; Yang, W.; Enmon, R. M.; Pellegrini, V. A.; Palm, S.; Borchardt, P. E.; McDevitt, M. R.; Scheinberg, D. A.; Sgouros, G.
Proceedings of the American Association for Cancer Research Annual Meeting (2002)

Fulltext@MSK | Save

Targeted α particle immunotherapy for myeloid leukemia

Journal Article

Jurcic, J. G.; Larson, S. M.; Sgouros, G.; McDevitt, M. R.; Finn, R. D.; Divgi, C. R.; Ballangrud, A. M.; Hamacher, K. A.; Ma, D.; Humm, J. L.; more...
Blood (2002)

Fulltext@MSK | Save

Response of LNCaP spheroids after treatment with an α-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591)

Journal Article

Ballangrud, A. M.; Yang, W. H.; Charlton, D. E.; McDevitt, M. R.; Hamacher, K. A.; Panageas, K. S.; Ma, D.; Bander, N. H.; Scheinberg, D. A.; Sgouros, G.
Cancer Research (2001)

Fulltext@MSK | Save

Relative efficacy of the alpha-particle emitters Bi-213 and Ac-225 for radioimmunotherapy against micrometastases: Dosimetric analysis and spheroid model response

Meeting Abstract

Ballangrud, A. M.; Yang, W. H.; Hamacher, K. A.; McDevitt, M. R.; Ma, D.; Scheinberg, D. A.; Sgouros, G.
Proceedings of the American Association for Cancer Research Annual Meeting (2000)

Fulltext@MSK | Save

Alpha particle emitter radioimmunotherapy of breast cancer micrometastases: Preclinical studies using MCF7 spheroids to assess response and microdosimetry following Hu3S193 (anti-le(y)) - Bi-213 treatment